BioMind, an Artificial Intelligence (AI) powered system, proficient in diagnosing neurological diseases such as meningioma and glioma with an accuracy rate of over 90% that can diagnose brain tumours and predict brain hematoma expansion cases and would prove to be incredibly valuable on being integrated to existing medical practices, has been developed by Artifi...